[go: up one dir, main page]

EP1007016A1 - Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre - Google Patents

Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre

Info

Publication number
EP1007016A1
EP1007016A1 EP98946274A EP98946274A EP1007016A1 EP 1007016 A1 EP1007016 A1 EP 1007016A1 EP 98946274 A EP98946274 A EP 98946274A EP 98946274 A EP98946274 A EP 98946274A EP 1007016 A1 EP1007016 A1 EP 1007016A1
Authority
EP
European Patent Office
Prior art keywords
coding
plaster
labeling according
information
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98946274A
Other languages
German (de)
English (en)
Inventor
Volker Siemund
Frank Becher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of EP1007016A1 publication Critical patent/EP1007016A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
    • G09F3/08—Fastening or securing by means not forming part of the material of the label itself
    • G09F3/10—Fastening or securing by means not forming part of the material of the label itself by an adhesive layer

Definitions

  • Adhesive sheet-like systems are known for the treatment of a large number of diseases and have proven themselves extremely well in many therapeutic areas of application.
  • Transdermal therapeutic systems with a systemic effect are also becoming increasingly important. Their advantage is, for example, a controlled, relatively long-term release of active ingredients through the skin.
  • TTS Transdermal therapeutic systems
  • Such a transdermal system has an impermeable and non-adhesive backing layer to protect against undesired escape of active substances and a pressure-sensitive adhesive layer for the necessary adhesion to the skin, which can at the same time contain active substances, as well as a removable, to protect loss of active substances during storage of a TTS. usually a protective layer with a non-adhesive finish.
  • a transdermal therapeutic system with a backing layer made of thermoplastic material consisting of a laminate of an outside, low-melting thermoplastic and a higher-melting thermoplastic facing the skin, consisting of a permanent, identifying coding attached to this backing layer in a locally different surface condition, surface thickness or surface roughness of this backing layer, as well as an active part containing the active ingredient.
  • the invention is that this coding of the backing layer is generated by the action of pressure, heat, ultrasound or abrasion. Limits of applicability when applying the known identifying coding result from the fact that exposure to pressure or heat can be harmful to many plasters containing active ingredients.
  • the capacity of a coding that can be produced by different surface properties of the back layer of a plaster is comparatively narrow.
  • an additional, final work step is required to manufacture them, for example on the finished system.
  • the invention is based on the object of specifying a label for both transdermal therapeutic and for non-transdermal dosage forms using a plaster as an information carrier and methods for its production which are problem-free and with a comparatively large scope provides information about properties, quantity, risks and / or side effects.
  • the task is solved by labeling, in which the patch is provided with an electronically identifiable coding.
  • Such coding has the advantage that it can be carried out or applied using known means, that it has a comparatively high storage capacity for information and with existing electronic reading means which any doctor, pharmacy, ambulance or medical center can have or carry with it , is decodable.
  • One embodiment provides that the coding is formed on the side of the patch facing away from the skin in the form of electronically readable numbers or letters or in the form of a bar code.
  • Comparatively extensive information texts can be stored on a coding field, for example the size of a standard postage stamp.
  • the coding is easily deciphered with an optical, also IR reading device.
  • the coding is designed in the form of a microchip on the side of the plaster facing away from the skin, such as is applied to insurance cards of health insurance companies, for example.
  • This has, for example, a dimension corresponding to approximately half the area of a stamp, can be produced at low cost and can be attached to a plaster.
  • the coding can also be designed on the side of the patch facing away from the skin in the form of a magnetic strip be similar to equipping a bank card with a magnetic stripe.
  • the coding can be present on the adhesive-free side of an adhesive film, which is viable on the plaster before or after its application to a patient's skin.
  • the marking according to the invention provides that the coding contains information about the type and amount of the active substance contained in the patch and, if applicable, all other materials.
  • the coding provided for labeling the dosage forms can, however, also advantageously contain further information about, for example, side effects of the therapeutic active substance, incompatibilities with other active substances and other noteworthy special features.
  • the labeling can be supplemented with great advantage, for example, in such a way that the coding contains instructions for administration of antidote in the event of recognizable occurrence of dangerous symptoms such as overdose of the active substance or acute side effects.
  • a particular advantage of labeling is that personal information about the carrier of the dermal or transdermal system can be stored in coded form. Especially for high-risk patients with an extensive medical history, information about existing allergies, drug intolerance, etc. can be included in the coding as patient-specific information content.
  • the basic structure of basic TTS types is described, for example, by YWChien: “Developmental Concepts and Practice in Transdermal Therapeutic Systems” in Transdermal Controlled Systemic Medications, ed. By YW Chien, Marcel Dekker, New York (1987), p.25-81.
  • the coding can be contained in a drug-containing or drug-free layer of the TTS.
  • a preferred embodiment contains the coding in a separate layer of a TTS located on the backing layer, consisting of backing layer and active substance-containing adhesive matrix layer.
  • a further preferred embodiment contains the coding in the back layer of a TTS, consisting of back layer and active substance-containing pressure-sensitive adhesive matrix layer.
  • Another preferred embodiment contains the coding in a separate layer of a TTS located between the backing layer and the active substance-containing adhesive matrix layer.
  • a further preferred embodiment contains the coding in a separate, on the backing layer of a TTS, consisting of backing layer, drug-containing reservoir, the rate of release of the drug-controlling membrane and a pressure-sensitive adhesive layer.
  • a further preferred embodiment contains the coding in the back layer of a TTS, consisting of back layer, reservoir containing the active substance, the speed the release of the active ingredient-controlling membrane and a pressure-sensitive adhesive layer.
  • a further preferred embodiment contains the coding in a separate layer of a TTS located under the backing layer, consisting of backing layer, reservoir containing the active ingredient, the rate of release of the active ingredient-controlling membrane and an adhesive layer.
  • a method for producing a marking of the type according to the preamble of claim 1 is characterized in that the coding is incorporated into or applied to the plaster when the plaster is being prepared.
  • the coding can advantageously be applied to the plaster in a printing process such as screen printing or pad printing or the like.
  • the coding can also be applied to the plaster using a pressure-sensitive adhesive carrier provided with the coding.
  • an advantageous method for producing a marking of the plaster provides that the coding is stored in a separate layer of a multilayer plaster, or in the layer containing the active substance or in the outer covering layer.
  • the labeling for both transdermal therapeutic and non-transdermal dosage forms using a plaster as an information carrier advantageously eliminates risk factors that cannot always be recognized quickly enough, for example of active ingredient combinations reacting to harmful side effects or in the case of a first pass effect as a result of a damaged TTS or an overdose, allergy reactions or the consequences of using an active ingredient after its expiry date.
  • the labeling according to the invention makes it possible for the doctor in such cases to remedy serious complications with targeted auxiliary measures, in particular in cases of life-threatening conditions.
  • the invention optimally achieves the object stated at the outset.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention porte sur des systèmes adhésifs plats - formes d'administration thérapeutique cutanée et transcutanée - mettant en oeuvre un emplâtre adhésif comme vecteur d'information, caractérisés en ce que l'emplâtre est doté d'un codage identifiable électroniquement.
EP98946274A 1997-08-22 1998-08-04 Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre Withdrawn EP1007016A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19736520A DE19736520A1 (de) 1997-08-22 1997-08-22 Kennzeichnung für klebende flächenförmige dermale und transdermale therapeutische Darreichungsformen unter Verwendung eines klebenden Plfasters als Informationsträger, sowie Verfahren zu seiner Herstellung
DE19736520 1997-08-22
PCT/EP1998/004846 WO1999009960A1 (fr) 1997-08-22 1998-08-04 Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre

Publications (1)

Publication Number Publication Date
EP1007016A1 true EP1007016A1 (fr) 2000-06-14

Family

ID=7839806

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98946274A Withdrawn EP1007016A1 (fr) 1997-08-22 1998-08-04 Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre

Country Status (16)

Country Link
EP (1) EP1007016A1 (fr)
JP (1) JP2001513547A (fr)
KR (1) KR20010023176A (fr)
AU (1) AU737379B2 (fr)
CA (1) CA2299715A1 (fr)
DE (1) DE19736520A1 (fr)
HU (1) HUP0004184A3 (fr)
ID (1) ID24885A (fr)
IL (1) IL134386A0 (fr)
NO (1) NO20000814D0 (fr)
NZ (1) NZ502830A (fr)
PL (1) PL338736A1 (fr)
SK (1) SK2322000A3 (fr)
TR (1) TR200000408T2 (fr)
WO (1) WO1999009960A1 (fr)
ZA (1) ZA987580B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141836A1 (de) * 2001-08-27 2003-03-27 Hartmann Paul Ag Medizinisches Set für die Verwendung zur Versorgung von Sonden- oder Katheteraustrittsstellen
WO2000004480A1 (fr) 1998-07-20 2000-01-27 Noven Pharmaceuticals, Inc. Procede de suivi individuel et d'identification de dispositif d'administration de medicament
DE19950295A1 (de) * 1999-10-19 2001-04-26 Beiersdorf Ag Verbandmaterial auf Folienbasis mit Aufdruck
GB9928511D0 (en) * 1999-12-03 2000-02-02 Secr Defence Brit Orally administrable pharmaceutical product and method of fabrication therefor
CA2393603C (fr) 1999-12-10 2010-09-21 Massachusetts Institute Of Technology Dispositifs a puces pour l'administration de molecules et procedes de fabrication correspondants
EP1688132A3 (fr) * 1999-12-10 2009-10-07 Massachussetts Institute of Technology dispositifs à puces pour l'administration de molécules et procédés de fabrication correspondants
US6551838B2 (en) 2000-03-02 2003-04-22 Microchips, Inc. Microfabricated devices for the storage and selective exposure of chemicals and devices
DE10015930A1 (de) * 2000-03-30 2001-10-18 Dieter Hafner Träger für ein Arzneimittel
US6730072B2 (en) 2000-05-30 2004-05-04 Massachusetts Institute Of Technology Methods and devices for sealing microchip reservoir devices
DE102006011340A1 (de) * 2006-03-09 2007-09-20 Grünenthal GmbH Wirkstoffhaltige Pflaster mit verbesserter Handhabung
DE102016105889A1 (de) * 2016-03-31 2017-10-05 Amw Gmbh Transdermales Applikationssystem mit Informationsschicht
CA3068458A1 (fr) * 2017-06-27 2019-01-03 Lts Lohmann Therapie-Systeme Ag Timbre transdermique a rappel automatique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
ES2019275B3 (es) * 1985-10-09 1991-06-16 Desitin Arzneimittel Gmbh Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE4223004A1 (de) * 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
DE9409784U1 (de) * 1994-06-10 1994-08-11 Effner Biomet Gmbh, 12247 Berlin Vorrichtung zur transdermalen Applikation von Wirkstoffen
JPH08712A (ja) * 1994-06-27 1996-01-09 Olympus Optical Co Ltd 二次元データコード付薬剤
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
DE19524083C2 (de) * 1995-07-01 2000-07-06 Lohmann Therapie Syst Lts Verfahren zur Entsorgung von Transdermalapplikations-Sondermüll
US5700998A (en) * 1995-10-31 1997-12-23 Palti; Yoram Drug coding and delivery system
DE19708674C2 (de) * 1996-03-25 2002-02-07 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer wirkstoffhaltigen Filmschicht und einer löslichen Trennschicht, sowie ein Verfahren zu dessen Herstellung
US5797898A (en) * 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9909960A1 *

Also Published As

Publication number Publication date
ID24885A (id) 2000-08-31
JP2001513547A (ja) 2001-09-04
NZ502830A (en) 2001-08-31
IL134386A0 (en) 2001-04-30
HUP0004184A3 (en) 2001-08-28
HUP0004184A2 (hu) 2001-04-28
KR20010023176A (ko) 2001-03-26
ZA987580B (en) 1999-02-23
TR200000408T2 (tr) 2000-09-21
AU737379B2 (en) 2001-08-16
WO1999009960A1 (fr) 1999-03-04
PL338736A1 (en) 2000-11-20
AU9338798A (en) 1999-03-16
NO20000814L (no) 2000-02-18
SK2322000A3 (en) 2000-07-11
DE19736520A1 (de) 1999-02-25
NO20000814D0 (no) 2000-02-18
CA2299715A1 (fr) 1999-03-04

Similar Documents

Publication Publication Date Title
DE3634016C2 (fr)
EP0889723B1 (fr) Systeme therapeutique transdermique a faible epaisseur de la zone d'application et a grande souplesse, et son procede de fabrication
DE3714140C2 (fr)
EP1007016A1 (fr) Systemes plats d'administration therapeutique cutanee et transcutanee mettant en oeuvre un emplatre adhesif comme vecteur d'information, et mode de fabrication d'un tel emplatre
EP1178783A1 (fr) Dispositif et procede pour augmenter la permeation transdermique de medicaments
DE10159745A1 (de) Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
WO2019025625A1 (fr) Système d'application contenant une matrice de micro-aiguilles présentant un principe actif pour la cicatrisation
EP3119444B1 (fr) Pansement de recouvrement à tolérance améliorée et longue durée d'adhérence et son procédé de fabrication
WO1998029143A1 (fr) Emplatre extremement souple a effet dermique ou transdermique et son procede de production
DE19708674C2 (de) Transdermales therapeutisches System mit einer wirkstoffhaltigen Filmschicht und einer löslichen Trennschicht, sowie ein Verfahren zu dessen Herstellung
CN110891647A (zh) 自提醒贴剂
DE3901551A1 (de) Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE19738643A1 (de) Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase
EP0374725B1 (fr) Système thérapeutique transdermique pour la norpseudoephédrine
EP1415649A1 (fr) Système thérapeutique transdermique d'oxybutynin
EP1121126A1 (fr) Procede pour traiter la schizophrenie et substance utilisee dans le cadre de ce procede
DE3319670A1 (de) Mittel zur beschleunigten transdermalen applikation von wirkstoffen und naehrstoffen
EP1107742A1 (fr) Pansement compose de trois couches et contenant un medicament
Sogerer Substitution im Maßregelvollzug
MXPA00001731A (en) Flat systems for cutaneous and percutaneous administration involving a sticking-plaster as an information carrier, and method for producing such a plaster
CZ2000579A3 (cs) Označení pro lepicí plošné dermální a transdermální terapeutické způsoby podávání za použití náplasti jako nosiče informací, jakož i způsob jeho výroby
Cardew The Mobile Unit in Action
DE102006019447A1 (de) Markierung von Botulinum Toxin
DD279404A5 (de) Flaechenfoermiges, therapeutisches system, verfahren zu seiner herstellung und seine verwendung
CH702866A2 (de) Kennzeichnungssystem.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 19991223

17Q First examination report despatched

Effective date: 20020408

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020820

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1029518

Country of ref document: HK